EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Relative efficacy of G and GM-CSFs in ameliorating toxicity in an intensive treatment protocol for advanced, diffuse B-cell NHLs, predominantly small noncleaved cell lymphomas



Relative efficacy of G and GM-CSFs in ameliorating toxicity in an intensive treatment protocol for advanced, diffuse B-cell NHLs, predominantly small noncleaved cell lymphomas



Blood 90(10 SUPPL 1 PART 1): 192A, Nov 15




(PDF emailed within 1 workday: $29.90)

Accession: 033173402

Download citation: RISBibTeXText



Related references

Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment. Leukemia & Lymphoma 57(7): 1723-1726, 2016

Efficacy and toxicity of brief duration, high intensity chemotherapy for small noncleaved cell lymphoma /L-3 acute lymphoblastic leukemia Results of CALGB 9251. Blood 96(11 Part 1): 829a, November 16, 2000

Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 79(5): 1282-1290, 1992

Pathologic and immunologic features of small transformed noncleaved cell lymphomas. Laboratory Investigation 46(1): 47A, 1982

BCL6 and p53 gene expression predict survival in the small noncleaved cell lymphomas. Modern Pathology 12(1): 133A, 1999

The efficacy and toxicity of the FUDR-based regimen in the treatment of advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 5(4): 290-292, 2002

Treatment of B-cell lymphomas in children and adults with a short duration intensive protocol. Anticancer Research 19(3A): 2028-2029, May-June, 1999

New drugs for the treatment of advanced-stage diffuse large cell lymphomas. Seminars in Hematology 43(4): 251-261, 2006

Pathologic quiz case 2. Malignant lymphoma, diffuse, small, noncleaved cell, Burkitt's type. Archives of Otolaryngology--Head & Neck Surgery 115(5): 636-7, 639, 1989

Efficacy and toxicity of pemetrexed or gemcitabine combined with cisplatin in the treatment of patients with advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 15(10): 569-575, 2014

Dose-intensified treatment of advanced-stage diffuse large B-cell lymphomas. Seminars in Hematology 43(4): 221-229, 2006

Differentiation between small noncleaved cell and lymphoblastic lymphomas a study of paraffin embedded fixed tissue sections using monoclonal antibodies. Laboratory Investigation: 9a, 1987

A multicenter randomized phase IIb efficacy study of Vx-001, a peptide-based cancer vaccine as maintenance treatment in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics. Clinical Lung Cancer 14(4): 461-465, 2014

Large proportion of Epstein-Barr virus-associated small noncleaved cell lymphomas among children with non-Hodgkin's lymphoma at a single institution in Moscow, Russia. American Journal of Clinical Oncology 22(5): 523-525, 1999

Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial. Blood 107(10): 4047-4052, 2006